261 related articles for article (PubMed ID: 29229991)
1. BOK promotes chemical-induced hepatocarcinogenesis in mice.
Rabachini T; Fernandez-Marrero Y; Montani M; Loforese G; Sladky V; He Z; Bachmann D; Wicki S; Villunger A; Stroka D; Kaufmann T
Cell Death Differ; 2018 Mar; 25(4):708-720. PubMed ID: 29229991
[TBL] [Abstract][Full Text] [Related]
2. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
3. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
4. Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.
Shang N; Bank T; Ding X; Breslin P; Li J; Shi B; Qiu W
Cell Death Dis; 2018 May; 9(5):558. PubMed ID: 29752472
[TBL] [Abstract][Full Text] [Related]
5. BCL-2 family member BOK promotes apoptosis in response to endoplasmic reticulum stress.
Carpio MA; Michaud M; Zhou W; Fisher JK; Walensky LD; Katz SG
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7201-6. PubMed ID: 26015568
[TBL] [Abstract][Full Text] [Related]
6. Activation of SRY accounts for male-specific hepatocarcinogenesis: Implication in gender disparity of hepatocellular carcinoma.
Liu C; Ren YF; Dong J; Ke MY; Ma F; Monga SPS; Wu R; Lv Y; Zhang XF
Cancer Lett; 2017 Dec; 410():20-31. PubMed ID: 28942012
[TBL] [Abstract][Full Text] [Related]
7. Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis.
Pok S; Wen V; Shackel N; Alsop A; Pyakurel P; Fahrer A; Farrell GC; Teoh NC
J Gastroenterol Hepatol; 2013 Sep; 28(9):1545-54. PubMed ID: 23574010
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model.
Scaiewicz V; Nahmias A; Chung RT; Mueller T; Tirosh B; Shibolet O
PLoS One; 2013; 8(12):e81065. PubMed ID: 24339898
[TBL] [Abstract][Full Text] [Related]
9. The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways.
Abd-Elbaset M; Mansour AM; Ahmed OM; Abo-Youssef AM
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1611-1624. PubMed ID: 32270258
[TBL] [Abstract][Full Text] [Related]
10. Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration.
Nozaki Y; Hikita H; Tanaka S; Fukumoto K; Urabe M; Sato K; Myojin Y; Doi A; Murai K; Sakane S; Saito Y; Kodama T; Sakamori R; Tatsumi T; Takehara T
Sci Rep; 2021 Feb; 11(1):3363. PubMed ID: 33564095
[TBL] [Abstract][Full Text] [Related]
11. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of Bcl-x protein during hepatocarcinogenesis induced exogenously and endogenously in rats.
Hatanaka Y; Nakae D; Mutai M; Hashizume K; Kamihara Y; Kinoshita N; Tani Y; Danno Gi G; Ohta S; Konishi Y; Ashida H
Jpn J Cancer Res; 2001 Dec; 92(12):1270-7. PubMed ID: 11749691
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
[TBL] [Abstract][Full Text] [Related]
14. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.
Hsu SH; Wang B; Kutay H; Bid H; Shreve J; Zhang X; Costinean S; Bratasz A; Houghton P; Ghoshal K
Am J Pathol; 2013 Dec; 183(6):1719-1730. PubMed ID: 24113455
[TBL] [Abstract][Full Text] [Related]
15. The Ubiquitin E3 Ligase TRIM21 Promotes Hepatocarcinogenesis by Suppressing the p62-Keap1-Nrf2 Antioxidant Pathway.
Wang F; Zhang Y; Shen J; Yang B; Dai W; Yan J; Maimouni S; Daguplo HQ; Coppola S; Gao Y; Wang Y; Du Z; Peng K; Liu H; Zhang Q; Tang F; Wang P; Gao S; Wang Y; Ding WX; Guo G; Wang F; Zong WX
Cell Mol Gastroenterol Hepatol; 2021; 11(5):1369-1385. PubMed ID: 33482392
[TBL] [Abstract][Full Text] [Related]
16. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
Zhang N; Chu ES; Zhang J; Li X; Liang Q; Chen J; Chen M; Teoh N; Farrell G; Sung JJ; Yu J
Oncotarget; 2014 Sep; 5(18):8330-40. PubMed ID: 25327562
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma as extracolonic manifestation of Lynch syndrome indicates SEC63 as potential target gene in hepatocarcinogenesis.
Casper M; Weber SN; Kloor M; Müllenbach R; Grobholz R; Lammert F; Zimmer V
Scand J Gastroenterol; 2013 Mar; 48(3):344-51. PubMed ID: 23537056
[TBL] [Abstract][Full Text] [Related]
19. Intracellular localization of the BCL-2 family member BOK and functional implications.
Echeverry N; Bachmann D; Ke F; Strasser A; Simon HU; Kaufmann T
Cell Death Differ; 2013 Jun; 20(6):785-99. PubMed ID: 23429263
[TBL] [Abstract][Full Text] [Related]
20. Bok is a genuine multi-BH-domain protein that triggers apoptosis in the absence of Bax and Bak.
Einsele-Scholz S; Malmsheimer S; Bertram K; Stehle D; Johänning J; Manz M; Daniel PT; Gillissen BF; Schulze-Osthoff K; Essmann F
J Cell Sci; 2016 Jun; 129(11):2213-23. PubMed ID: 27076518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
